What is PTC Therapeutics's capex?

PTC Therapeutics (PTCT) reported capex of $1.2M in Q1 2026.

How has PTC Therapeutics's capex changed year-over-year?

PTC Therapeutics's capex decreased by 30.6% year-over-year, from $1.72M to $1.2M.

What is the long-term trend for PTC Therapeutics's capex?

Over 3 years (2021 to 2025), PTC Therapeutics's capex has grown at a -32.0% compound annual growth rate (CAGR), from $28.21M to $8.86M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

PTC Therapeutics PTCT CapEx

CapEx at other companies

BioMarin PharmaceuticalsBMRN

$20.92M+24.8%

BridgeBio PharmaBBIO

$69K—

Arrowhead ResearchARWR

$2.57M-51.6%

United TherapeuticsUTHR

$100.8M+34.6%

BiogenBIIB

$51.2M+38.0%

ALN

Alnylam PharmaceuticalsALNY

——

Other financials

Income statement

See full

Revenue$272.6M-76.8%

Operating income$45.0M-95.4%

Net income-$2.8M-100%

EPS (diluted)-$0.03-100%

Balance sheet

See full

Cash & equivalents$834.0M-43.7%

Total debt$395.1M+0.1%

Total equity-$180.5M+2.9%

Total assets$2.9B+8.0%

Cash flow

See full

Operating cash flow-$59.0M-107%

Free cash flow-$60.2M-107%

Valuation

See full

Market cap$6.55B+40.3%

Enterprise value$6.11B+77.3%

P/E8×—

P/S7.9×+5.3×

Profitability

See full

Gross margin96%—

Operating margin1.6%-38.7pp

Net margin42.3%+27.4pp

FCF margin39.1%+32.8pp

Returns & leverage

See full

Return on equity-216.7%—

Debt / equity372.3×—

Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is PTC Therapeutics's capex?: PTC Therapeutics (PTCT) reported capex of $1.2M in Q1 2026.
How has PTC Therapeutics's capex changed year-over-year?: PTC Therapeutics's capex decreased by 30.6% year-over-year, from $1.72M to $1.2M.
What is the long-term trend for PTC Therapeutics's capex?: Over 3 years (2021 to 2025), PTC Therapeutics's capex has grown at a -32.0% compound annual growth rate (CAGR), from $28.21M to $8.86M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.